Commercially Available Gene Expression Assays as Predictive Tools for Adjuvant Radiotherapy? A Critical Review

BACKGROUND: Gene expression assays are increasingly used for decision-making regarding adjuvant chemotherapy in patients with hormone receptor-positive, HER2-negative breast cancer. There are some clinical situations in which there is also a need for better prognostic and predictive markers to bette...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Breast Care (Basel)
Auteurs principaux: Krug, David, Baumann, René, Budach, Wilfried, Duma, Marciana Nona, Dunst, Jürgen, Feyer, Petra, Fietkau, Rainer, Haase, Wulf, Harms, Wolfgang, Hehr, Thomas, Piroth, Marc D., Sedlmayer, Felix, Souchon, Rainer, Wenz, Frederik, Sauer, Rolf
Format: Artigo
Langue:Inglês
Publié: S. Karger GmbH 2020
Sujets:
Review Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7204850/
https://ncbi.nlm.nih.gov/pubmed/32398980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000505656
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires